StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.17−0.03 (-1.36%)

Close on Nov 16, 2026Market cap $138.23MP/E –Yield –

MacroGenics total assets

Total assets on the balance sheet at the end of each period.

MacroGenics's total assets was $345.41M at Jun 30, 2026. For fiscal 2025 it was $256.85M, down 1.8% from the year before. Over ten years it grew -3.3% a year on average. The highest annual figure on record is $378.74M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$256.85M-1.8%
FY2024Dec 31, 2024$261.66M-12.3%
FY2023Dec 31, 2023$298.42M+6.4%
FY2022Dec 31, 2022$280.47M-16.3%
FY2021Dec 31, 2021$335.25M-11.5%
FY2020Dec 31, 2020$378.74M+21.2%
FY2019Dec 31, 2019$312.50M-5.9%
FY2018Dec 31, 2018$332.13M-11.2%
FY2017Dec 31, 2017$373.88M+20.1%
FY2016Dec 31, 2016$311.26M-13.4%
FY2015Dec 31, 2015$359.27M+106.6%
FY2014Dec 31, 2014$173.89M+38.2%
FY2013Dec 31, 2013$125.78M+134.0%
FY2012Dec 31, 2012$53.75M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$345.41M+40.7%
Q1 FY2026Mar 31, 2026$217.87M-3.0%
Q4 FY2025Dec 31, 2025$256.85M-1.8%
Q3 FY2025Sep 30, 2025$270.76M+2.4%
Q2 FY2025Jun 30, 2025$245.42M+22.0%
Q1 FY2025Mar 31, 2025$224.57M-9.6%
Q4 FY2024Dec 31, 2024$261.66M-12.3%
Q3 FY2024Sep 30, 2024$264.49M-22.2%
Q2 FY2024Jun 30, 2024$201.14M-34.2%
Q1 FY2024Mar 31, 2024$248.29M-27.7%
Q4 FY2023Dec 31, 2023$298.42M+6.4%
Q3 FY2023Sep 30, 2023$339.97M+74.0%
Q2 FY2023Jun 30, 2023$305.65M+40.2%
Q1 FY2023Mar 31, 2023$343.50M+26.5%
Q4 FY2022Dec 31, 2022$280.47M-16.3%
Q3 FY2022Sep 30, 2022$195.35M-50.2%
Q2 FY2022Jun 30, 2022$218.04M-48.8%
Q1 FY2022Mar 31, 2022$271.45M-37.7%
Q4 FY2021Dec 31, 2021$335.25M-11.5%
Q3 FY2021Sep 30, 2021$392.16M+4.7%
Q2 FY2021Jun 30, 2021$425.91M+30.0%
Q1 FY2021Mar 31, 2021$435.45M+64.1%
Q4 FY2020Dec 31, 2020$378.74M+21.2%
Q3 FY2020Sep 30, 2020$374.38M+6.5%
Q2 FY2020Jun 30, 2020$327.59M-14.6%
Q1 FY2020Mar 31, 2020$265.41M-36.0%
Q4 FY2019Dec 31, 2019$312.50M-5.9%
Q3 FY2019Sep 30, 2019$351.45M-1.1%
Q2 FY2019Jun 30, 2019$383.68M-0.8%
Q1 FY2019Mar 31, 2019$414.64M+27.2%
Q4 FY2018Dec 31, 2018$332.13M-11.2%
Q3 FY2018Sep 30, 2018$355.36M+46.9%
Q2 FY2018Jun 30, 2018$386.89M+40.8%
Q1 FY2018Mar 31, 2018$326.08M+18.7%
Q4 FY2017Dec 31, 2017$373.88M+20.1%
Q3 FY2017Sep 30, 2017$241.85M-28.8%
Q2 FY2017Jun 30, 2017$274.85M–
Q1 FY2017Mar 31, 2017$274.72M–
Q4 FY2016Dec 31, 2016$311.26M–
Q3 FY2016Sep 30, 2016$339.86M–

More MacroGenics figures

See a number that looks wrong?